Filing Details

Accession Number:
0001209191-18-011324
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-20 16:21:56
Reporting Period:
2018-02-15
Accepted Time:
2018-02-20 16:21:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI Pharmaceutical Preparations (2834) 263931704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1603510 Brett Christopher Primiano C/O Karyopharm Therapeutics Inc.
85 Wells Avenue
Newton MA 02459
Evp, Cbo, Gc & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-02-15 1,014 $15.02 8,867 No 4 S Direct
Common Stock Disposition 2018-02-16 1,486 $15.01 7,381 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.04, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
  3. Represents the weighted average sale price. These shares were sold in transactions at $15.00 and $15.08. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.